Shanghai Fanyu Health Pharmaceutical Technology Co., Ltd. was established in September 2013 and is located in the Zhangjiang High-Tech Park in Shanghai. It is the drug R&D center in Shanghai under Joincare Pharmaceutical Group Industry Co., Ltd. In July 2015, with the support of the group, Shanghai Fanyu Health Pharmaceutical Technology Co., Ltd. and Guangzhou Institute of Respiratory Diseases led by Academician Zhong Nanshan jointly established Guangzhou Jiankangyuan Respiratory Drug Engineering Technology Co., Ltd.
Shanghai Fanyu Health Pharmaceutical Technology Co., Ltd. has an excellent R&D team composed of multi-level scientific and technical personnel, including doctors, masters, and undergraduates. It is equipped with more than 140 special equipment with a total value exceeding 20 million yuan, including various inhalation preparation efficacy evaluation devices adopted by the US and European pharmacopoeias, respiratory simulators for different populations, and inhalation preparation-specific dynamic laser diffraction particle size analyzers, as well as other professional analytical instruments such as HPLC.
Shanghai Fanyu Health Pharmaceutical Technology Co., Ltd. focuses on the research and development of therapeutic drugs in the field of major diseases, especially the development of inhalation preparations mainly for the treatment of respiratory diseases; it is engaged in pre-prescription research, pre-clinical pharmaceutical research, project R&D research, technical consultation, and registration services related to drug R&D.
R&D Team and Project Achievements
The company's R&D team has been committed to the research and industrialization of new drug formulations, involving inhalation administration, oral controlled-release administration, injection of poorly soluble or thermally unstable drugs, and pre-formulation research in multiple fields.
In the nearly three years since its establishment, the company has been involved in the R&D of more than 20 projects, including innovative drugs, generic drugs, and drug-device combinations. Two projects have been submitted for clinical trials, one project has obtained clinical approval; six projects are pending submission; two Class 1 new drug R&D projects have received funding from the Shanghai Science and Technology Commission (project numbers: 15431903800 and 16431902500); one inhalation preparation R&D project has received funding from the Pudong New Area Science and Technology Commission (project number: PKF2015-CO4). In 2014, the company was approved by the Shanghai Science and Technology Commission to establish the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform" (project number: 14DZ2293300), and cooperated with the Shanghai Food and Drug Packaging Materials Testing Institute to jointly establish the "Shanghai Drug Compatibility Research Professional Technical Service Platform" (project number: 14DZ2293500).
Shanghai Respiratory System Drug Delivery Professional Technical Service Platform
Taking the construction of the "Shanghai Respiratory System Drug Delivery Professional Technical Service Platform" as an opportunity, Shanghai Fanyu Health Pharmaceutical Technology Co., Ltd. has established a research service platform for the research, evaluation, and engineering development of respiratory system drugs, specializing in the development and industrialization of key engineering technologies for respiratory system drug varieties. By breaking through the bottlenecks of variety design and domestic production, it accelerates the transformation of technological achievements and industrial technology upgrades, providing CRO services of formulation research and related technical consulting for domestic and foreign pharmaceutical companies and research institutions.
Third-Party Testing Services
Combined with the R&D of respiratory drug delivery systems, the company focuses on inhalation preparation-related testing and quality evaluation, actively building a third-party pharmaceutical testing service platform, and engaging in quality research and testing work related to drug R&D. An application for testing laboratory accreditation (CNAS) has been submitted to the China National Accreditation Service for Conformity Assessment.
Shanghai Fanyu Health Pharmaceutical Technology Co., Ltd. sincerely welcomes pharmaceutical companies, universities, and research institutions from home and abroad to cooperate and exchange.
Contact Information:
Building 1, No. 899, Zuchong Road, Pudong New Area, Shanghai
Contact Person: Mr. Wen
Tel: 021-58368016
Fax: 021-58368002
